Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02195999 · ClinicalTrials.gov registry record
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 9
- Enrollment target
NCT02195999: Completed study, sponsored by University of Florida.
NCT02195999 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02195999 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne muscular dystrophy (DMD) in affected individuals over time, as well as determine whether peripheral skeletal muscle dysfunction can predict cardiopulmonary dysfunction. The central hypothesis is that non-invasive MRI measures of the heart, muscle, and peripheral skeletal muscles can sensitively predict future cardiopulmonary decline.
Primary Outcome
The MRI T2 and MRS will be used as a noninvasive marker of myocardial damage/inflammation of participants of this study as an early detection for DMD.
Interventions
- OTHER Magnetic Resonance Imaging (MRI)
- OTHER Echocardiogram
- OTHER Pulmonary Function Testing (PFT)
- OTHER Metabolic Exercise Testing using stationary bicycle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-03-06 |
What the finished NCT02195999 record still lists
NCT02195999 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02195999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02195999 about?
NCT02195999 is a clinical study titled "Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy". This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne muscular dystrophy (DMD) in affected individuals over time, as well as determine whether peripheral...
What is the current status of trial NCT02195999?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2013-12. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT02195999?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (OTHER), Echocardiogram (OTHER), Pulmonary Function Testing (PFT) (OTHER), Metabolic Exercise Testing using stationary bicycle (OTHER).
Who is sponsoring clinical trial NCT02195999?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia